Approval · Notice of Compliance 2029 · 1999
REQUIP: Notice of Compliance 2029
Issued July 28, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2029
- Date
- July 28, 1999
- Company
- Smithkline Beecham Pharma, Division Of Smithkline Beecham Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strengths
- Therapeutic class
- Antiparkinsonian agent/dopamine agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REQUIP | 02240542 | — |
| REQUIP | 02240543 | — |
Medicinal ingredients
- ROPINIROLE HYDROCHLORIDE 3 MG per TAB
- ROPINIROLE 4 MG per TAB